Noida, India

Dayanand Panpatil

USPTO Granted Patents = 6 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Uttar Pradesh, IN (2022)
  • Noida, IN (2021 - 2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Dayanand Panpatil: Innovator in Kinase Inhibitors and Therapeutic Compounds

Introduction

Dayanand Panpatil is a notable inventor based in Noida, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors and therapeutic agents. With a total of 6 patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Heterocyclic compounds as kinase inhibitor and uses thereof." This patent focuses on compounds that are useful in treating conditions associated with Checkpoint kinase (CHK), specifically CHK-1 enzymes. The invention discloses a compound of formula (IA) that exhibits inhibitory activity against CHK-1 enzymes. It also outlines methods for treating conditions linked to excessive activity of CHK-1 enzymes, along with pharmaceutical compositions, kits, and methods of synthesis.

Another significant patent by Panpatil is related to "Inhibitors of fibroblast activation protein." This patent describes compounds and compositions that modulate fibroblast activation protein (FAP). These compounds may serve as therapeutic agents for treating hyperproliferative diseases, showcasing the versatility and importance of his research.

Career Highlights

Throughout his career, Dayanand Panpatil has worked with various companies, including Praxis Biotech LLC and Sperogenix Therapeutics Limited. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to innovative research.

Collaborations

Some of his notable coworkers include Brahmam Pujala and Sebastian Bernales. Their collaborative efforts have likely enhanced the quality and impact of the research conducted in their respective fields.

Conclusion

Dayanand Panpatil's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an innovator. His work in developing kinase inhibitors and therapeutic compounds is paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…